Table 1 General characteristics of 17 c-TA patients
Features | Patients (17) |
|---|---|
Current age, years | 18.7 (15.7–20.7) |
Median disease duration, years | 10.4 (7.0–11.6) |
Diagnosis delay, months | 11.0 (4.0–30.0) |
Clinical remission disease, n (%) | 16 (94) |
Elevated APR, n (%) | 6 (35.3) |
Positive PET, n (%) | 15 (88.2) |
Positive MRA, n (%) | 10 (58.8) |
Imunossupressive therapy, n (%) | 8 (50) |
Combined therapy with biologic agents, n (%) | 8 (50) |
Off medication | 1 (5.9) |